Prevnar IS Safe – Have a Look at the Studies!

March 16, 2009 by · 8 Comments
Filed under: Vaccine Science 

In November of 2008, a report was published about a halted vaccine trial in India. Here is an excerpt which can be found on Livemint :

New Delhi: Patient trials of an advanced pneumonia vaccine by the domestic unit of US drug giant Wyeth Inc. have been suspended by India’s drug quality regulator after the death of an infant on whom the vaccine was tested in a trial in Bangalore.
The child had a pre-existing cardiac disorder. Indian drug rules prohibit testing on human subjects with such conditions without the prior approval of the drugs controller general of India (DCGI), the drugs quality regulator.

Indian authorities said that the trial was stopped because:

“The baby was suffering from a cardiac abnormality and should not have been included in the trial at all. It seems that the ‘inclusion-exclusion’ criteria protocol has not been adhered to by the investigator,” said Surinder Singh, drugs controller general. “We have suspended all further trials across the country.”

Read more

New vaccine

July 8, 2008 by · 2 Comments
Filed under: Vaccine Science 
Eleven years ago, Professor Adrian Lee, head of the School of Microbiology and Immunology at the University of New South Wales commented on the failure of the first Helicobacter vaccine to work in a European trial. The Astra Research Center in Boston, USA collaborated with the New South Wales University on the project. Professor Lee believed that two or three recombinant antigens, and a much more potent adjuvant were required. Not only did the first vaccine, which had only one antigen, not work, but the e. coli and cholera toxin adjuvants caused diarrhoea in the vaccine recipients.

Read more

© 2010-2017 Inside Vaccines All Rights Reserved -- Copyright notice by Blog Copyright